Tamimoto, Y., Horiuchi, T., Tsukamoto, H., Otsuka, J., Mitoma, H., Kimoto, Y., ...
Objective. Accumulating evidence suggests that B-cell depletion therapy by rituximab may be effective for autoimmune disorders. However, an optimal dose of rituximab and a mechanism of its action...
Miyagawa, H., Yamai, M., Sakaguchi, D., Kiyohara, C., Tsukamoto, H., Kimoto, Y., ...
Objective. Identification of the genes responsible for systemic lupus erythematosus (SLE). Methods. All the exons and putative promoter regions of 53 candidate genes (TNFRSF6/Fas, TNFSF6/FasL, Fli1,...
Meta- and Pooled Analysis of GSTT1 and Lung Cancer: A HuGE-GSEC Review (2006)
Raimondi, S, Paracchini, V, Autrup, H, Barros-Dios, JM, Benhamou, S, Boffetta, P, ...
Lung cancer is the most common malignancy in the Western world, and the main risk factor is tobacco smoking. Polymorphisms in metabolic genes may modulate the risk associated with environmental...
Nagayama, J, Kiyohara, C, Masuda, Y, Kuratsune, M
Aryl hydrocarbon hydroxylase (AHH)-inducing potency of eight polychlorinated dibenzofuran (PCDF) isomers, 3,4,5,3',4',5'-hexachlorobiphenyl (HCB) and 2,3,7,8-tetrachlorodibenzo-p-dioxon (TCDD) in two...
Nagayama, J, Kiyohara, C, Masuda, Y, Kuratsune, M
Aryl hydrocarbon hydroxylase (AHH)-inducing potency of eight polychlorinated dibenzofuran (PCDF) isomers, 3,4,5,3',4',5'-hexachlorobiphenyl (HCB) and 2,3,7,8-tetrachlorodibenzo-p-dioxon (TCDD) in two...